Page 42 - stop

Hisfarma-IAI → 2018 – 2022 : Standar Praktik
ICDx

Dx Rx Ax nRx PC3

Px

Ox
“IT-Application”

I→ To whom serve:

R→ Hisfarma 2018 C→ 1. Patient

J→ 1.Review E→ 2. Clients IMPACTS

I → 2.Needs/Problem G→ 3. Consumer RISK
4. Costumer
3.Intervention
W→ 4.Portfolio A→ 5. Familiy BENEFITS

A→ 5.Monevact A→ 6. Public

7. Population

PC3

at HOME